Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
agency
-
-
CompaniesMolnupiravirSun Pharma
Sun Pharma arm receives DCGI approval for Molnupiravir in India
by adminby adminSynopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
-
SYNOPSIS: The UN health agency said the Covid strain first discovered in southern Africa was a “highly divergent variant with a high…
-
Agrochemicals
Rotam Expands Into New Markets with JOYA Herbicide Featuring Flumioxazin 51%.
by adminby adminSUMMARY: Rotam, a global leader in superior crop protection products, announces the launch of JOYA™, a versatile professional herbicide featuring the active…
-
Active Pharmaceutical Ingredients (API)Ronapreve & Regkirona
EMA Recommends Authorisation of Two Monoclonal Antibody Medicines Ronapreve & Regkirona for Covid-19
by adminby adminTwo monoclonal antibody medicines for treating COVID-19 have been recommended for authorisation by the European Medicines Agency on Thursday (11 November), sparking…
-
Agrochemicals
Sun Pharma Plans to Launch Merck’s Covid pill Molnupiravir Under the Brand Name Molxvir® in India Soon.
by adminby adminKEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the anti-viral drug from Merck Sharpe Dohme and…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
-
Agrochemicals
Novavax partner of Serum Institute of India Receives Emergency Use Authorization for COVID-19 Vaccine (COVOVAX) in Indonesia.
by adminby adminKEYPOINTS: Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in…
-
Iptacopan
Novartis Pharmaceuticals UK awarded an Innovation Passport for Investigational Oral Therapy Iptacopan (LNP023)
by adminby adminSUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G) and is currently being investigated in a…
-
CompaniesNovartis
Novartis’s BLA has been accepted by US FDA & EMA for Kymriah (Tisagenlecleucel) to treat patients with relapsed or refractory follicular lymphoma.
by adminby adminNovartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T cell therapy Kymriah (Tisagenlecleucel) as third-line therapy…
Newer Posts